PH006 — Stress Resilience
Capacity to buffer, adapt to, and recover from stress exposure.
How well the system buffers stress, adapts under pressure, and returns toward baseline afterward.
Therapeutic areas: TA001 ★TA002TA003TA006
Provenance: Core Version 1 registry phenome for adaptive stress buffering. Benchmarked against RDoC Negative Valence and Arousal systems; distinct from Stress Reactivity (PH015) per RF002. (origin: BRAIN)
Related phenomes: PH015 — Stress Reactivity
External framework cross-references
RDoC domains
- Negative Valence Systems — sustained threat / stress adaptation
- Arousal and Regulatory Systems — stress regulation
DSM / ICD context
- Generalised anxiety disorder
- Post-traumatic stress disorder — resilience contexts
Foundational Evidence
Evidence Confidence: Low–Medium
Registry-level score for this phenome's foundational evidence stack — not Biology → Phenome Confidence on individual mechanism pages.
Endocannabinoid and stress-adaptation reviews are strong; human dietary stress-resilience outcomes are indirect (omega-3 anxiety, oatmeal preclinical adjunct).
Registry-level foundational evidence for this phenome. Mechanism pages link to phenome IDs and carry relationship-specific evidence — not duplicated here.
Construct landmark papers
- Garani et al. (2021) — Endocannabinoid system in stress modulation and behavioural adaptation.
- Oades et al. (2010) — Monoaminergic systems in stress-related motivation and affect — ADHD-adjacent framing.
Biology → phenome landmark papers
- Watson et al. (2019) — Emerging gut–brain signalling and stress-related neuroimmune biology.
- Mamiya et al. (2021) — Precision psychiatry framing for excitation–inhibition balance in stress-related phenotypes.
Nutrition → biology landmark papers
- Kiecolt-Glaser et al. (2011) — Omega-3 reduced anxiety and inflammatory markers under stress — human resilience biology.
- Sean Davies et al. (2018) — Oatmeal bioactive context for gut–brain and stress-related signalling (preclinical/adjunct).
Connected mechanisms
BRS-X(ECS)
- BRS-X(ECS-PM1) — NAPE → NAE Biosynthesis Capacity (modulates · low-medium)
- BRS-X(ECS-PM2) — Omega-3-Derived Endocannabinoidome Signalling (modulates · low-medium)
- BRS-X(ECS-PM3) — FAAH-Mediated Endocannabinoid Preservation (modulates · low-medium)
- BRS-X(ECS-PM5) — Endocannabinoid Stress-Buffering Capacity (supports · low-medium)
- BRS1-FM1-PM4 — Serotonergic Signalling Regulation (supports · low-medium)
- BRS2-FM2-PM6 — Glutathione Synthesis (modulates · low-medium)
BRS3
- BRS3-FM2-PM3 — Nrf2-ARE Antioxidant Activation (modulates · low)
- BRS3-FM2-PM6 — Antioxidant Network Recycling (modulates · low-medium)